<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">94456</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Vitamin D deficiency: the cause or the result of obesity?</article-title><trans-title-group xml:lang="ru"><trans-title>Дефицит витамина D: причина или следствие ожирения?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karonova</surname><given-names>T. L</given-names></name><name xml:lang="ru"><surname>Каронова</surname><given-names>Татьяна Леонидовна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, зав. НИЛ клинической эндокринологии Института эндокринологии ФГБУ СЗФМИЦ, доц. каф. терапии факультетской с курсом эндокринологии и клиникой ГБОУ ВПО Первый СПбГМУ им. акад.И.П.Павлова</p></bio><email>karonova@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shmonina</surname><given-names>I. A</given-names></name><name xml:lang="ru"><surname>Шмонина</surname><given-names>Ирина Александровна</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант каф. терапии факультетской с курсом эндокринологии и клиникой ГБОУ ВПО Первый СПбГМУ им. акад.И.П.Павлова</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Andreeva</surname><given-names>A. T</given-names></name><name xml:lang="ru"><surname>Андреева</surname><given-names>Алена Тимуровна</given-names></name></name-alternatives><bio xml:lang="ru"><p>клинический ординатор Института эндокринологии ФГБУ СЗФМИЦ</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bairamov</surname><given-names>A. A</given-names></name><name xml:lang="ru"><surname>Байрамов</surname><given-names>Алекбер Азизович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, вед. науч. сотр. НИЛ клинической эндокринологии Института эндокринологии ФБГУ СЗФМИЦ</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Beliaeva</surname><given-names>O. D</given-names></name><name xml:lang="ru"><surname>Беляева</surname><given-names>Ольга Дмитриевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. терапии факультетской с курсом эндокринологии и клиникой ГБОУ ВПО Первый СПбГМУ им. акад.И.П.Павлова</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">V.A.Almazov North-West federal medical research center of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ Северо-Западный федеральный медицинский исследовательский центр им. В.А.Алмазова Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">I.M.Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2016</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en">VOL 18, NO4 (2016)</issue-title><issue-title xml:lang="ru">ТОМ 18, №4 (2016)</issue-title><fpage>49</fpage><lpage>52</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/94456">https://consilium.orscience.ru/2075-1753/article/view/94456</self-uri><abstract xml:lang="en"><p>This article discusses the cause-effect of the relationship between obesity and Vitamin D deficiency, both of them being very important medical conditions. The study results showed high comorbidity of these conditions and a negative effect of obesity on vitamin D deficiency development. According to the study results, obese patients need to lose more than 5% weigh and use large doses of cholecalciferol to prevent or treat vitamin D deficiency.</p></abstract><trans-abstract xml:lang="ru"><p>Настоящая статья посвящена оценке причинно-следственных взаимоотношений между такими метаболическими нарушениями, как ожирение и дефицит витамина D, каждое из которых представляет собой важную проблему современной медицины. Проведенное исследование продемонстрировало высокую коморбидность данных состояний и негативную роль избыточного количества жировой массы в развитии недостатка и дефицита витамина D. Полученные данные свидетельствуют о необходимости снижения массы тела более чем на 5% от исходного значения и использования больших доз колекальциферола у больных ожирением для лечения недостатка и дефицита витамина D.</p></trans-abstract><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>overweight</kwd><kwd>vitamin D deficiency</kwd><kwd>25(OH)D</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>избыточная масса тела</kwd><kwd>дефицит витамина D</kwd><kwd>25(ОН)D</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Holick M. F. Vitamin D Deficiency. N Engl J Med 2007; 357 (3): 266-81.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Muscogiuri G, Sorice G.P, Ajjan R et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis 2012; 22 (2): 81-7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Somjen D, Weisman Y, Kohen F et al. 25-hydroxyvitamin D3-1-alpha - hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005; 111 (Iss. 11): 1666-71.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81 (3): 353-73.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Adams J.S, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-8.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Каронова Т.Л., Гринева Е.Н., Никитина И.Л. и др. Распространенность дефицита витамина D в Северо-Западном регионе РФ среди жителей г. Санкт-Петербурга и г. Петрозаводска. Остеопороз и остеопатии. 2013; 3: 3-7.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Goldner W.S, Stoner J.A, Thompson J et al. Prevalence of vitamin D insufficiency in morbidly obese patients: comparison with non - obese controls. Obes Surg 2008; 18: 145-50.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Никитина И.Л., Каронова Т.Л., Гринева Е.Н. Дефицит витамина Д и здоровье. Артериальная гипертензия. 2010; 16 (3): 277-81.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Earthman C.P, Beckman L.M, Masodkar K, Sibley S.D. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. International J Obes Advance online publication. 21 jun 2011.- doi:10.1038/ijo.2011.119.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Каронова Т.Л., Гринева Е.Н., Михеева Е.П. и др. Уровень витамина D и его взаимосвязь с количеством жировой ткани и содержанием адипоцитокинов у женщин репродуктивного возраста. Проблемы эндокринологии. 2012; 6: 19-24.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: implications on vitamin d levels. Int Med J 2009; 39 (4): 256-8.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wortsman J, Matsuoka L.Y, Chen T.C et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Li J, Byrne M.E, Chang E et al. 1Alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008; 112: 122-6.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Targher G, Bertolini L, Scala L al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non - alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517-24.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5 (4): 513-20.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Canavan B, Salem R.O, Schurgin S et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Mеtab 2005; 90 (10): 5779-85.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care 2004; 27 (12): 2813-8.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Matsunuma A, Horiuchi N. Leptin attenuates gene expression for renal 25-hydroxy - vitamin D(3) -1 alpha - hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys 2007; 463 (1): 118-27.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kong J, Li Y.C. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006; 290: 916-24.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Gonzales A.M, Orlando R.A. Role of adipocyte - derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (London) 2007; 4 (1): 22.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The Evidence Report. National Institutes of Health. National Heart, Lung, and Blood Institute. Obes Res 1998; 6 (2): 51S-209S.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>IDF Consensus Worldwide Definition of Metabolic Syndrome: booklet [Electronic resourse]. International Diabetes Federation. Worldwide Definition of Metabolic Syndrome 2006. Mode of access: Internet via World Wide Web. URL: http://www.idf.org/webdata/docs/IDF_Metasyndrome_difinition.pdf. Title from title screen: 24.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Heaney R.P, Murad M.H, Weaver. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Клинические рекомендации Российской ассоциации эндокринологов. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. 2015. http://www.endocrincentr.ru/images/material-images/D/ 2019042014.pdf</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Лесняк О.М., Никитинская О.А., Торопцова Н.В. и др. Профилактика, диагностика и лечение дефицита витамина D и кальция у взрослого населения России и пациентов с остеопорозом (по материалам подготовленных клинических рекомендаций). Научно - практическая ревматология. 2015; 53 (4): 403-8.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The Evidence Report / National Institutes of Health. National Heart, Lung, and Blood Institute. Obes Res 1998; 6 (Suppl. 2): 51S-209S.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Национальные рекомендации по кардиоваскулярной профилактике Всероссийского научного общества кардиологов. Кардиоваскулярная терапия и профилактика (Прил. 2.). 2011; 10 (6).</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Никитина И.Л., Тодиева А.М., Каронова Т.Л. и др. Взаимосвязь уровня витамина D, содержания адипоцитокинов и метаболических нарушений у детей с ожирением. Бюл. ФЦСКЭ им. В.А.Алмазова. 2013; 20 (3): 37-46.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Каронова Т.Л., Беляева О.Д., Чубенко Е.А. и др. Способ повышения уровня витамина D у женщин с абдоминальным ожирением и высоким риском развития метаболического синдрома : пат. 2560345 Рос. Федерация : МПК7 H 04 В 1/38, Н 04 J 13/00. 20.08.15. Бюл. №23.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Rock C.L, Emond J.A, Flatt S.W et al. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity 2012; 20: 2296-301.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Pludowski P, Karczmarewicz E, Bayer M et al Practical guidelnes for te supplementation of vitamin D and the treatment of deficits in Central Europe - reccomendation of vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013; 64: 319-27.</mixed-citation></ref></ref-list></back></article>
